{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:59:20Z","timestamp":1769191160027,"version":"3.49.0"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,5,27]],"date-time":"2004-05-27T00:00:00Z","timestamp":1085616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respirology"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:p><jats:bold>Objective:\u2003<\/jats:bold> There is so far no consensus on the optimal treatment strategy for the coronavirus\u2010associated severe acute respiratory syndrome (SARS). We aimed to analyse the outcomes of a standard treatment strategy comprising antibiotics, a combination of ribavirin, a 3\u2010week step\u2010down course of corticosteroids, and the possibility of pulsed methylprednisolone rescue in the event of deterioration.<\/jats:p><jats:p><jats:bold>Methodology:\u2003<\/jats:bold> This was a prospective cohort study performed at a major public\u2010funded hospital in Hong Kong. Eighty\u2010eight World Health Organisation\/Centers for Disease Control and Prevention probable cases of SARS (97% laboratory\u2010confirmed) were treated with a standard protocol previously reported. Seventy\u2010one patients treated <jats:italic>de novo<\/jats:italic> were analysed in detail with regard to time to clinical stabilization after combination treatment, requirement of additional therapy (pulsed methylprednisolone; assisted ventilation); and final outcomes (recovery, mortality).<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> The mean age was 42. Twenty\u2010one patients (24%) had comorbidities. Three of 71 treated <jats:italic>de novo<\/jats:italic> recovered with antibiotics alone. The remaining 68 received combination treatment at a mean of 5.8 days after symptom onset, of whom 30 subsequently required pulsed methylprednisolone rescue (independent predictors: older age and higher LDH) and 18 required assisted ventilation (independent predictors: older age, higher oxygen requirement and creatinine level). Their median time to clinical stabilization was 8.0 days after combination treatment (independent predictor for longer time to stabilization: median age of 41 or above). Common complications were hyperglycaemia (58%), pneumo\u2010mediastinum\/thoraces (13%), psychiatric manifestations (7%) and ventilator\u2010associated pneumonia (2%). One patient (1%) died of SARS\u2010related respiratory failure. All\u2010cause mortality was 3.4%, occurring in patients aged &gt; 65 years only. None of the discharged survivors required continuation of oxygen therapy.<\/jats:p><jats:p><jats:bold>Conclusions:\u2003<\/jats:bold> This standard treatment protocol resulted in overall satisfactory outcomes. Randomized controlled trial is suggested to confirm its efficacy.<\/jats:p>","DOI":"10.1111\/j.1440-1843.2004.00588.x","type":"journal-article","created":{"date-parts":[[2004,5,27]],"date-time":"2004-05-27T07:31:32Z","timestamp":1085643092000},"page":"173-183","source":"Crossref","is-referenced-by-count":28,"title":["Outcome of coronavirus\u2010associated severe acute respiratory syndrome using a standard treatment protocol"],"prefix":"10.1111","volume":"9","author":[{"given":"Arthur Chun\u2010Wing","family":"LAU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loletta Kit\u2010Ying","family":"SO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora Pui\u2010Ling","family":"MIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond Wai\u2010Hung","family":"YUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"POON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Man\u2010Tat","family":"CHEUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretta Yin\u2010Chun","family":"YAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,5,27]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030666"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030781"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030747"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13077-2"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030685"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13412-5"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.21.JOC30885"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0909.030362"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13265-5"},{"key":"e_1_2_6_11_2","unstructured":"World Health Organization.Case Definitions for Surveillance of Severe Acute Respiratory Syndrome (SARS).[cited 6 July 2003]. Available from: URL:http:\/\/www.who.int\/csr\/sars\/casedefinition\/en\/print.html."},{"key":"e_1_2_6_12_2","unstructured":"Centers for Disease Control and Prevention.Updated Interim US Case Definition for Severe Acute Respiratory Syndrome (SARS).[cited 6 July 2003]. Available from: URL:http:\/\/www.cdc.gov\/ncidod\/sars\/casedefinition.htm."},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1373\/49.6.953"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-4825(90)90013-F"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13410-1"},{"key":"e_1_2_6_16_2","first-page":"399","article-title":"Treatment of severe acute respiratory syndrome with lopnavir\/ritonavir: a multicentre retrospective matched cohort study","volume":"9","author":"Chan KS","year":"2003","journal-title":"Hong Kong Med. J."},{"key":"e_1_2_6_17_2","first-page":"199","article-title":"Treatment of severe acute respiratory syndrome with convalescent plasma","volume":"9","author":"Wong VW","year":"2003","journal-title":"Hong Kong Med. J."},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.05320-0"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13615-X"},{"key":"e_1_2_6_20_2","first-page":"918","article-title":"Editorial overview. Severe acute respiratory syndrome treatement: Present status and future strategy","volume":"4","author":"Lau ACW","year":"2003","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.160.7.3487","article-title":"Ribavirin inhibits viral\u2010induced macrophage production of TNG, IL\u20101, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response","volume":"160","author":"Ning Q","year":"1998","journal-title":"J. Immunol."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-79-10-2381"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.3.751"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.115.3.901"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.5.1625"},{"key":"e_1_2_6_26_2","first-page":"932","article-title":"A case of mumps pneumonia complicated with acute respiratory failure","volume":"38","author":"Fujita K","year":"2000","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.2.426"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0911.030400"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.3.9807080"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2305012"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200306-766OC"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.2.159"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/106002809202600915","article-title":"Adjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients","volume":"26","author":"Sistek CJ","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"e_1_2_6_34_2","first-page":"648","article-title":"Potentiation of butylated\u2010hydroxytoluene\u2010induced acute lung damage by oxygen. Effects of prednisolone and indomethacin","volume":"128","author":"Hakkinen PJ","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-5-1-25"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0245com"}],"container-title":["Respirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1843.2004.00588.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1843.2004.00588.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T18:23:28Z","timestamp":1697307808000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1843.2004.00588.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,27]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1440-1843.2004.00588.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1843.2004.00588.x","archive":["Portico"],"relation":{},"ISSN":["1323-7799","1440-1843"],"issn-type":[{"value":"1323-7799","type":"print"},{"value":"1440-1843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,27]]}}}